| 2024-05-22 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 4,350 0.0062% | $2.64 | $11,485 | -0.95% | |
| 2023-10-11 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 785 0.0012% | $2.02 | $1,586 | +20.34% | |
| 2023-09-11 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 711 0.0011% | $2.20 | $1,564 | -4.42% | |
| 2023-08-11 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 682 0.0011% | $2.36 | $1,610 | -8.4% | |
| 2023-07-11 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 687 0.0007% | $2.34 | $1,608 | -1.54% | |
| 2023-06-12 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 610 0.0006% | $2.64 | $1,610 | -11.72% | |
| 2023-05-11 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 562 0.0008% | $2.89 | $1,624 | -25.5% | |
| 2023-04-11 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 840 0.0013% | $1.84 | $1,545 | +20.77% | |
| 2023-03-13 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 892 0.0013% | $1.75 | $1,564 | +13.9% | |
| 2023-02-13 | Sale | Trevi Therapeutics, Inc. TRVI | Chief Financial Officer | 8,474 0.0131% | $2.45 | $20,761 | -13.47% |